Veterinary valnemulin, novel liposome formulation of the salt thereof and preparation method thereof

A Vonimulin and liposome technology, applied in the directions of liposome delivery, ester active ingredients, antibacterial drugs, etc., can solve the problems of lack of drug liposome preparations, the number of varieties is too small, etc. The number of doses, the effect of increasing the effect, the effect of prolonging the duration of action

Active Publication Date: 2010-06-23
BEIJING DABEINONG ANIMAL HEALTH TECH +1
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are few related studies on veterinary liposome preparations at home and abroad, and the research on veterinary liposome preparations is mainly based on anti-paras

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Veterinary valnemulin, novel liposome formulation of the salt thereof and preparation method thereof
  • Veterinary valnemulin, novel liposome formulation of the salt thereof and preparation method thereof
  • Veterinary valnemulin, novel liposome formulation of the salt thereof and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] The preparation of embodiment 1 warnemulin hydrochloride liposome

[0031] 1) Dissolve 1000 mg of lecithin and 100 mg of cholesterol in 20 ml of chloroform, place in a round bottom flask, and evaporate and dry in vacuum on a rotary evaporator until a dry thin layer is formed;

[0032] 2) Dissolve 150mg of warnemulin hydrochloride in 25ml of PBS;

[0033] 3) Add warnemulin hydrochloride PBS solution into the flask, shake and hydrate to obtain warnemulin hydrochloride liposomes.

Embodiment 2

[0034] The preparation of embodiment 2 warnimulin liposomes

[0035] 1) Dissolve 2000mg of lecithin and 100mg of cholesterol in 20ml of chloroform-ether (1:1, V / V), and place in a round bottom flask;

[0036] 2) Dissolve 40mg of warnemulin in 20ml of PBS solution;

[0037] 3) Add the PBS solution of Vernemulin into the flask, carry out ultrasonic emulsification for 3min, and then evaporate under reduced pressure. After reaching the colloidal state, add 5ml of PBS solution dropwise, and continue to evaporate under reduced pressure, that is, the liposome of Vernemulin .

Embodiment 3

[0038] The preparation of embodiment 3 warney muulin phosphate liposomes

[0039] 1) Dissolve 1000mg of soybean lecithin and 150mg of cholesterol in 30ml of ether and place in a beaker;

[0040] 2) Dissolving 2000mg of warnemulin phosphate in 25ml of PBS solution;

[0041] 3) Under heating and stirring at 60°C, inject the PBS solution of warnemulin phosphate, and continue stirring until the diethyl ether is completely evaporated to obtain the warnemulin phosphate liposome.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle size rangeaaaaaaaaaa
Login to view more

Abstract

The invention relates to veterinary valnemulin, a novel liposome formulation of the salt thereof and a preparation method thereof, which belongs to the field of veterinary antibiotic preparations. In the preparation, valnemulin and the salt thereof serve as the main components, phospholipid and cholesterol serve as membranes, and the common liposomes, the lung targeting liposomes or the long circulating liposomes of valnemulin or valnemulin salt can be prepared. The valnemulin and the liposomes of the salt thereof have better tissue selectivity compared with the common preparation, are effective to the bacterial and mycoplasma infection in cells, and can reduce the toxic and side effect. The lung targeting liposomes targets the medicine to the lung, and has significant effect to the mycoplasma infection of the lung, bacterial infection and the like, and reduces the toxic and side effect. The long circulating liposomes significantly improves the circulation time of the liposomes in the body, so that the medicines displays the efficacy for a longer time more effectively, so s to reduce the delivery times and the dosage.

Description

technical field [0001] The invention belongs to the field of veterinary antibiotic preparations, and relates to a new liposome dosage form of warnemulin and its salt and a preparation method thereof. Background technique [0002] Valnemulin and its salts are a new bag of pleuromutilin semi-synthetic antibiotics, which belong to diterpenes and belong to the same class of drugs as tiamulin. They are animal-specific antibiotics and are mainly used to prevent and treat pigs, Mycoplasmosis and Gram-positive bacterial infections in cattle, sheep and poultry. In 1999, it was approved by the European Community for the prevention and treatment of swine dysentery caused by Brachyspira hyodysenteriae infection and swine enzootic pneumonia caused by Mycoplasma pneumoniae infection. It is the first veterinary drug premix approved in Europe. Classified as a prescription drug for veterinary use. [0003] Ordinary preparations of warnemulin, such as: premixes, injections, etc. After admin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/22A61K9/127A61P31/04
Inventor 田玲刘澜莫云葛冰冯华兵文波葛代兴丛日刚黄建茹谢先仁
Owner BEIJING DABEINONG ANIMAL HEALTH TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products